Aytu BioPharma, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
NANTAHALA CAPITAL MANAGEMENT, LLC | 05/15/2025 | 1.09 M | $1.30 M | 0.00% | 17.72% |
STONEPINE CAPITAL MANAGEMENT, LLC | 05/14/2025 | 463.72 K | $795.00 K | 13.78% | 7.56% |
RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 76.82 K | $92.19 K | 1.86% | 1.25% |
ARMISTICE CAPITAL, LLC | 05/15/2025 | 57.60 K | $69.12 K | -61.60% | 0.94% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 53.94 K | $64.75 K | 26.24% | 0.88% |
CITADEL ADVISORS LLC | 05/15/2025 | 30.49 K | $36.59 K | 175.66% | 0.50% |
VANGUARD GROUP INC | 05/09/2025 | 27.89 K | $33.47 K | 0.00% | 0.45% |
BLACKROCK, INC. | 05/02/2025 | 22.79 K | $27.35 K | 0.00% | 0.37% |
JAFFETILCHIN INVESTMENT PARTNERS, LLC | 04/24/2025 | 17.44 K | $20.92 K | 100.00% | 0.28% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 14.87 K | $17.84 K | 100.00% | 0.24% |
ACADIAN ASSET MANAGEMENT LLC | 05/21/2025 | 14.62 K | $17.00 K | 0.00% | 0.24% |
TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2025 | 4.69 K | $5.63 K | 78.91% | 0.08% |
MAI CAPITAL MANAGEMENT | 05/15/2025 | 3.58 K | $4.29 K | 0.00% | 0.06% |
ADVISOR GROUP HOLDINGS, INC. | 05/12/2025 | 300 | $360 | 0.00% | 0.00% |
MORGAN STANLEY | 05/15/2025 | 290 | $348 | 0.00% | 0.00% |
UBS GROUP AG | 05/13/2025 | 262 | $314 | -82.49% | 0.00% |
WELLS FARGO & COMPANY/MN | 05/13/2025 | 124 | $148 | 0.00% | 0.00% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 103 | $124 | 3.00% | 0.00% |
CIBC PRIVATE WEALTH GROUP, LLC | 05/14/2025 | 83 | $84 | 0.00% | 0.00% |
05/02/2025 | 61 | $73 | 0.00% | 0.00% | |
GROUP ONE TRADING, L.P. | 05/14/2025 | 37 | $44 | 0.00% | 0.00% |
BNP PARIBAS ARBITRAGE, SNC | 05/14/2025 | 23 | $28 | 0.00% | 0.00% |
NEWEDGE ADVISORS, LLC | 05/15/2025 | 21 | $25 | 0.00% | 0.00% |
JONES FINANCIAL COMPANIES LLLP | 05/28/2025 | 12 | $15 | 100.00% | 0.00% |
MOSER WEALTH ADVISORS, LLC | 04/22/2025 | 10 | $12 | 100.00% | 0.00% |
CREDIT AGRICOLE S A | 05/14/2025 | 5 | $6 | 0.00% | 0.00% |
SJS INVESTMENT CONSULTING INC. | 04/15/2025 | 5 | $6 | 0.00% | 0.00% |
VISION FINANCIAL MARKETS LLC | 05/09/2025 | 2 | $3 | 100.00% | 0.00% |
JPMORGAN CHASE & CO | 05/12/2025 | 0 | $0 | -100.00% | 0.00% |
US BANCORP \DE\ | 05/08/2025 | 0 | $0 | -100.00% | 0.00% |
DIMENSIONAL FUND ADVISORS LP | 05/13/2025 | 0 | $0 | -100.00% | 0.00% |
MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
TWO SIGMA SECURITIES, LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
Aytu BioPharma, Inc. institutional Ownership - FAQ's
During the previous two years, 33 institutional investors and hedge funds held shares of Aytu BioPharma, Inc.. The most heavily invested institutionals were:
Nantahala Capital Management, LLC: 1.09 M
Stonepine Capital Management, LLC: 463,721
RENAISSANCE TECHNOLOGIES LLC: 76,823
ARMISTICE CAPITAL, LLC: 57,597
GEODE CAPITAL MANAGEMENT, LLC: 53,944
CITADEL ADVISORS LLC: 30,493
30.59% of Aytu BioPharma, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 1.90 M shares in the last 24 months. This purchase volume represents approximately $3.76 M in transactions.